SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Sampre Nutritions Ltd

BSE: 530617 NSE: ISIN: INE375C01022
  |   Sector:  FMCG   |   Industry:  Consumer Food

Snapshot

Q.1 Which industry/sub-sector does Sampre Nutritions Ltd belong to?
Sampre Nutritions Ltd belongs to the FMCG sector, operating specifically within the Consumer Food segment.
Q.2 Is Sampre Nutritions Ltd a good quality company?
Sampre Nutritions Ltd is a weak quality company, based on a inconsistent 10 year financial track record.
Q.3 Is Sampre Nutritions Ltd undervalued or overvalued?
Sampre Nutritions Ltd appears Overvalued, as its key valuation ratios are above with their past averages.
Q.4 Is Sampre Nutritions Ltd a good buy now?
Sampre Nutritions Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Sampre Nutritions Ltd?
Sampre Nutritions Ltd revenue growth is -0.1% for FY-2025 , which is below its 5 year CAGR of 0.2% , indicating slower growth.
Q.2 Gross Profit margin of Sampre Nutritions Ltd?
Sampre Nutritions Ltd Gross profit margin which is the profit after deduction of direct costs, is -20.7% for FY-2025 , which is below its 5 year median of 8.7% , indicating decreasing margins.
Q.3 Operating Profit Margin of Sampre Nutritions Ltd?
Sampre Nutritions Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is -14.86% for FY-2025 , which is below its 5 year median of 15.21% indicating decreasing margins.
Q.4 Net Profit Margin of Sampre Nutritions Ltd?
Sampre Nutritions Ltd Net Profit Margin is -29.09% for FY-2025 , is below with its 5 year median of 0.94%, indicating decreasing margins.
Current Level Historic Median
Gross Profit Margin -20.7 8.7
Operating Profit Margin -14.86 15.21
Net Profit Margin -29.09 0.94
Q.5 Return on Asset of Sampre Nutritions Ltd?
Sampre Nutritions Ltd Return on Asset is -9.03%, which is below its 5 year historical median of 0.7%, indicating deteriorated asset utilization efficiency.
Q.6 Return on Equity (ROE) of Sampre Nutritions Ltd?
Sampre Nutritions Ltd Return on equity is -13.12% for FY-2025 , which is below its historical median of 1.57%, indicating the business is making worse use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Sampre Nutritions Ltd?
Sampre Nutritions Ltd Return on capital employed is -7.13% for FY-2025 , which is below its estimated weighted average cost of capital(WACC) 14%, indicating value preservation.
Q.8 Cash conversion cycle of Sampre Nutritions Ltd?
Sampre Nutritions Ltd Cash conversion cycle is 165 days, above its historical median of 130 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.31 0.57
ROE -13.12 1.57
ROCE -7.13 6.38
Cash Conversion Cycle 165 days 130 days
Q.9 Debt to Equity ratio of Sampre Nutritions Ltd?
Sampre Nutritions Ltd Debt-to-Equity ratio is 0.19 , which is lower with the industry average of 0.49 , indicating lower debt levels in the industry.
Q.10 Debt to cash flow from operations of Sampre Nutritions Ltd?
Sampre Nutritions Ltd Debt to cash flow from operations is 196.56 , which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Sampre Nutritions Ltd?
Promoters hold 15.26% of the Sampre Nutritions Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Sampre Nutritions Ltd vs industry peers?
Sampre Nutritions Ltd revenue CAGR is 0.22% , compared to the industry median CAGR of 6.97% , indicating stable growth and maintaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 25.1 117.4
Gross Profit -5.2 5
Operating Profit -4 7
Net Profit -7 2.6
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.31 1.2
ROE -13.12 7.15
ROCE -7.13 10.41
Cash Conversion Cycle (days) 165.17 51

Valuation & price assessment

Q.1 Stock return of Sampre Nutritions Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of -1.6% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price -1.6% 31% -11.8% 124.1%
Q.3 Valuation ratios of Sampre Nutritions Ltd vs historical?
The current P/E is lower that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings - 49.79 51.80
Price to Book 1.18 0.81 2.42
Price to Sales 4.31 0.46 1.42
EV to EBITDA -157.43 8.42 14.55

Check more companies

1. Hatsun Agro Product
2. Bikaji Foods Inter.
3. Zydus Wellness
4. LT Foods
5. Devyani Internatl.
6. Orkla India
7. Manorama Industries
8. KRBL
9. Dodla Dairy
10. Mrs.Bectors Food
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×